Galapagos | Omsætningsaktiver



Current Assets Lave om Dato
AstraZeneca USD 25.83B 1.67B 2024-12
Biogen USD 7.46B 626.3M 2024-12
Genmab DKK 27.85B 4.16B 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 17B 301M 2024-12
GRIFOLS EUR 5.73B 404.28M 2024-12
Hikma Pharmaceutical USD 2.28B 185M 2024-06
Incyte USD 3.24B 430.32M 2024-12
Merck EUR 13.93B 882M 2024-09
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 30.08B 589M 2024-06
UCB EUR 4.79B 1.47B 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



Galapagos Omsætningsaktiver - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.